MedPath

Evaluating the Efficacy of Opti-Speech for Speech Treatment

Not Applicable
Completed
Conditions
Dysarthria
Articulation Disorder
Prelingual Deafness
Interventions
Device: Opti-Speech
Registration Number
NCT02705326
Lead Sponsor
Vulintus, Inc.
Brief Summary

The purpose of this study is to determine if feedback from a three-dimensional real-time visualization of the tongue, a program called Opti-Speech, can be used to improve speech.

Detailed Description

Participants will be asked to complete the Goldman Fristoe Test of Articulation along with several other assessment tests. Then speech treatment, guided by Opti-Speech, will be provided to the participant for up to 10 treatment sessions. The participant will be asked to come back after the final treatment for a 2-month follow-up assessment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
37
Inclusion Criteria
  • English speaking individuals with speech errors resulting from persistent speech sound disorder, individuals with dysarthria resulting from neurological disorders and individuals with pre-lingual or congenital deafness.
Exclusion Criteria
  • Cognitive impairments that affect their ability to understand and follow instructions by the treating speech language pathologists

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Opti-SpeechOpti-SpeechSpeech treatment will be guided by Opti-Speech's visual feedback of tongue movement during speech
Primary Outcome Measures
NameTimeMethod
Percent articulatory accuracywithin 30 minutes of treatment

Sound probe lists will be administered within 30 minutes of treatment. Probe lists will be scored as correct or incorrect. The percentage of probes correct will be calculated

Secondary Outcome Measures
NameTimeMethod
Change in Accuracy of Speech Sound Production from Pre-Treatment to Post-TreatmentImmediately prior to first speech treatment and 2 months after final treatment.

The Goldman Fristoe Test of Articulation will be administered prior to any speech treatment with Opti-Speech and again 2 months after the final speech treatment session. The percentage of consonants correct (PCC) will be used to assess the change in accuracy of speech sound production from pre-treatment to post-treatment

Trial Locations

Locations (2)

The Cleveland Hearing and Speech Center

🇺🇸

Cleveland, Ohio, United States

Callier Center for Communication Disorders at UT Dallas

🇺🇸

Richardson, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath